Treatment of children persistently infected with hepatitis B virus: Seroconversion or suppression

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 6, 2007, Pages 1189-1192

  Price, Nicola ^a   Boxall, Elizabeth H ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antiviral therapy; DNA replication; HBV

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; CLEVUDINE; ENTECAVIR; GLUCOCORTICOID; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LAMIVUDINE; PEGINTERFERON; PLACEBO; PREDNISOLONE; TELBIVUDINE; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW SUPPRESSION; CHILDHOOD DISEASE; CHRONIC ACTIVE HEPATITIS; CLINICAL TRIAL; CROSS RESISTANCE; DNA REPLICATION; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; EDITORIAL; FLU LIKE SYNDROME; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MONOTHERAPY; MYALGIA; NONHUMAN; PATIENT COMPLIANCE; PROGNOSIS; SEROCONVERSION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE; WEIGHT REDUCTION;

ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA REPLICATION; DRUG THERAPY, COMBINATION; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INTERFERON-ALPHA; LAMIVUDINE; TREATMENT OUTCOME;

EID: 36448930524     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm362     Document Type: Editorial

References (31)

1. Liu CJ, Kao JH, Chen DS. Therapeutic implications of hepatitis B virus genotypes. Liver Int 2005; 25: 1097-107.
2. Kelly D, Boxall E. Neonatal and paediatric infection. In: Thomas HC, Lemon S, Zuckerman AJ, eds. Viral Hepatitis. 3rd Edn. Oxford, UK: Blackwell Publishing, 2005; 714-39.
3. Brook MG, Chan G, Yap I et al. Randomised controlled trial of lymphoblastoid interferon alpha in Europid men with chronic hepatitis B virus infection. BMJ 1989; 299: 652-6.
4. Hoofnagle JH, Peters M, Mullen KD et al. Randomised, controlled trial of recombinant human alpha interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-25.
5. Saracco G, Mazzella G, Rosina F et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989; 10: 336-41.
6. Niederau C, Heintges T, Lange S et al. Long-term follow-up of HbeAg-positive patients treated with interferon alpha for chronic hepatitis B. N Engl J Med 1996; 334: 1470-1.
7. Prescott LM. Lamivudine useful against hepatitis B-HIV co-infection. J Int Assoc Physicians AIDS Care 1995; 1: 34.
8. Allen MI, Deslauriers M, Andrews CW et al. Identification and characterisation of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998; 27: 1670-7.
9. Keeffe EB, Marcellin P. New and emerging treatment of chronic hepatitis B. Clin Gastoenterol Hepatol 2007; 5: 285-94.
10. Lok ASF, McMahon BJ. Chronic hepatitis B. AASLD Practice Guidelines. Hepatology 2007; 45: 507-39.
11. Torre D, Tambini R. Interferon-α therapy for chronic hepatitis B in children: A meta-analysis. Clin Infect Dis 1996; 23: 131-7.
12. Vo Thi Diem H, Bourgois A, Bontems P et al. Chronic hepatitis B infection: Long term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005; 40 141-5.
13. Bortolotti F, Jara P, Barbera C et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46 715-8.
14. Lai CL, Lin HJ, Lau JN et al. Effect of recombinant alpha 2 interferon with or without prednisolone in Chinese HbsAg carrier children. Q J Med 1991; 78: 155-63.
15. Yuen MF, Hui CK, Cheng CC et al. Long-term follow-up of interferon alpha treatment in Chinese patients with chronic hepatitis B infection: the effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 2001; 34: 139-45.
16. Kao JH, Wu NH, Chen PJ et al. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33: 998-1002.
17. Erhardt A, Blondin D, Hauck K et al. Response to interferon alpha is hepatitis B virus genotype dependent: Genotype A is more sensitive to interferon than genotype D. Gut 2005; 54: 1009-13.
18. Nair PV, Tong MJ, Stevenson D et al. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. Hepatology 1986; 6: 1319-24.
19. Mellerup MT, Krogsgaard K, Mathurin P et al. Sequential combination of glucocorticosteroids and alpha interferon versus alpha interferon alone for HBeAg-positive chronic hepatitis B. Cochrane Database Syst Rev 2005; issue 3: CD000345.
20. Boxall EH, Sira J, Ballard AL et al. Long-term follow up of hepatitis B carrier children treated with interferon and prednisolone. J Med Virol 2006; 78: 888-95.
21. Jonas MM, Kelley DA, Mizerski J et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1706-13.
22. Sokal EM, Kelly DA, Mizerski J et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006; 43: 225-32.
23. Yang H, Qi X, Sabogal A et al. Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. Antivir Ther 2005; 10: 625-33.
24. Tenney DJ, Levine SM, Rose RE. Clinical emergence of entecavir-resistant hepatitis 8 virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob Agents Chemother 2004; 48 3498-507.
25. Gerolami R, Bourliere M, Colson P et al. Unusual selection of rta181V HBV mutants cross-resistant to adefovir under lamivudine monotherapy: Report of two cases. J Clin Virol 2006; 36 Suppl 2: S92.
26. Schalm SW, Heathcote J, Cianciara J et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial. Gut 2000; 46: 562-8.
27. Dikici B, Bosnak M, Bosnak V et al. Comparison of treatments of chronic hepatitis B in children with lamivudine and α-interferon combination and α-interferon alone. Pediatr Int 2002; 44: 517-21.
28. Dikici B, Ozgenc F, Kalayci AG et al. Current therapeutic approaches in childhood chronic hepatitis B infection: A multicenter study. J Gastroenterol Hepatol 2004; 19: 127-33.
29. D'Antiga L, Aw M, Atkins M et al. Combined lamivudine/ interferon-α treatment in 'immunotolerant' children perinatally infected with hepatitis B: A pilot study. J Pediatr 2006; 148 228-33.
30. Sobaniec-Lotowska ME, Lebensztejn DM. Histological outcome of chronic hepatitis B in children treated with interferon alpha. World J Gastroenterol 2005; 11: 7179-82.
31. Liaw YF, Sung JJ, Chow WG et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-31.